Naveen Pemmaraju

Naveen Pemmaraju and Fadi Haddad In New Episode of Cancerwise Podcast on The Future of Leukemia Treatment

MD Anderson Cancer Center shared aa post on LinkedIn:

“How do doctors know if leukemia treatment is working?
Doctors are using minimal residual disease (MRD) to monitor response and personalize care.
In this podcast episode, Dr. Naveen Pemmaraju and Dr. Fadi Haddad explain what MRD is and what it could mean for the future of leukemia treatment.”

Listen Full Podcast.

More posts featuring MD Anderson Cancer Center on OncoDaily.